Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria.

Area of Science:

• Genetics
• Biochemistry
• Molecular Biology

Background:

• Acute intermittent porphyria (AIP) is a rare autosomal dominant disorder resulting from deficient hydroxymethylbilane synthase (HMBS) activity.
• AIP attacks are characterized by neurovisceral symptoms linked to heme biosynthesis dysfunction.

Purpose of the Study:

• To investigate the impact of 117 reported HMBS gene mutations on protein structure and function in AIP.
• To identify novel pathogenic mutations in the HMBS gene using bioinformatic prediction.
• To explore potential genetic factors, such as PPARA, contributing to AIP pathogenesis and population disparities.

Main Methods:

• Collected and analyzed 117 HMBS gene mutations from individuals with AIP.
• Evaluated mutation impacts on HMBS protein structure and function, focusing on the dipyromethane cofactor (DPM) binding domain.
• Utilized bioinformatic prediction algorithms to assess pathogenicity of all possible missense HMBS mutations.
• Analyzed the distribution patterns of 23 variations across eight ethnic populations.

Main Results:

• Several severe AIP-associated mutations were localized to the HMBS DPM binding domain, suggesting a significant impact on catalytic activity.
• Identified 34 novel pathogenic HMBS mutations with low allele frequencies.
• Found evidence suggesting a role for the PPARA gene in AIP attack mechanisms.
• Observed distinct distribution patterns of HMBS variations across different ethnic populations.

Conclusions:

• The study enhances understanding of AIP's molecular mechanisms by characterizing HMBS mutations and their functional consequences.
• Identification of novel pathogenic mutations and potential contributing genes like PPARA aids in improving AIP diagnosis and treatment strategies.
• Analysis of population-specific mutation distributions offers insights into the genetic basis of AIP prevalence disparities.